最初的体外生命支持组织（ELSO）指导文件：用于患有严重心肺衰竭的COVID-19患者的体外膜肺氧合（ECMO）
Initial ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure.
作者信息
Bartlett Robert H, Ogino Mark T, Brodie Daniel, McMullan David M, Lorusso Roberto, MacLaren Graeme, Stead Christine M, Rycus Peter, Fraser John F, Belohlavek Jan, Salazar Leonardo, Mehta Yatin, Raman Lakshmi, Paden Matthew L
机构信息
From the Extracorporeal Life Support Organization, Ann Arbor, Michigan.
Department of Paediatrics, Division of Neonatology, Nemours Alfred I duPont Hospital for Children, Wilmington, Delaware.
出版信息
ASAIO J. 2020 May;66(5):472-474. doi: 10.1097/MAT.0000000000001173.
Abstract
Disclaimer: ECMO has, and will certainly continue, to play a role in the management of COVID-19 patients. It should be emphasized that this initial guidance is based on the current best evidence for ECMO use during this pandemic. Guidance documents addressing additional portions of ECMO care are currently being assembled for rapid publication and distribution to ECMO centers worldwide.
摘要
免责声明
体外膜肺氧合（ECMO）已经并肯定会继续在新型冠状病毒肺炎（COVID-19）患者的治疗中发挥作用。应当强调的是，本初步指南基于本次大流行期间使用ECMO的当前最佳证据。目前正在汇编涉及ECMO护理其他部分的指南文件，以便迅速发布并分发给全球的ECMO中心。
相似文献
1
Initial ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure.最初的体外生命支持组织（ELSO）指导文件：用于患有严重心肺衰竭的COVID-19患者的体外膜肺氧合（ECMO）
ASAIO J. 2020 May;66(5):472-474. doi: 10.1097/MAT.0000000000001173.
2
Erratum: Initial ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure.勘误：初始体外生命支持组织（ELSO）指导文件：用于患有严重心肺衰竭的新冠肺炎患者的体外膜肺氧合（ECMO）
ASAIO J. 2020 Aug;66(8):e113. doi: 10.1097/MAT.0000000000001219.
3
Implementation of new ECMO centers during the COVID-19 pandemic: experience and results from the Middle East and India.COVID-19 大流行期间新的体外膜肺氧合（ECMO）中心的实施：来自中东和印度的经验和结果。
Intensive Care Med. 2021 Aug;47(8):887-895. doi: 10.1007/s00134-021-06451-w. Epub 2021 Jun 22.
4
[Outcome of pediatric extracorporeal membrane oxygenation in a single center].[单中心小儿体外膜肺氧合治疗的结果]
Zhonghua Er Ke Za Zhi. 2018 Feb 2;56(2):122-127. doi: 10.3760/cma.j.issn.0578-1310.2018.02.009.
5
Setting Up an ECMO Program in a South American Country: Outcomes of the First 104 Pediatric Patients.在一个南美国家建立体外膜肺氧合（ECMO）项目：首批104例儿科患者的治疗结果
World J Pediatr Congenit Heart Surg. 2015 Jul;6(3):374-81. doi: 10.1177/2150135115589788.
6
The changing demographics of neonatal extracorporeal membrane oxygenation patients reported to the Extracorporeal Life Support Organization (ELSO) Registry.向体外生命支持组织（ELSO）登记处报告的新生儿体外膜肺氧合患者的人口统计学变化。
Pediatrics. 2000 Dec;106(6):1334-8. doi: 10.1542/peds.106.6.1334.
7
Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: analysis of the Extracorporeal Life Support Organization (ELSO) registry.体外膜肺氧合用于肺移植术后原发性移植肺功能障碍：体外生命支持组织（ELSO）注册研究分析
J Heart Lung Transplant. 2007 May;26(5):472-7. doi: 10.1016/j.healun.2007.01.031.
8
Cardiopulmonary resuscitation requiring extracorporeal membrane oxygenation in the elderly: a review of the Extracorporeal Life Support Organization registry.老年患者需体外膜肺氧合的心肺复苏：体外生命支持组织登记的回顾。
ASAIO J. 2013 May-Jun;59(3):211-5. doi: 10.1097/MAT.0b013e31828fd6e5.
9
Aspergillus infection and extracorporeal membrane oxygenation support.曲霉属感染与体外膜肺氧合支持。
J Intensive Care Med. 2013 May-Jun;28(3):178-84. doi: 10.1177/0885066611432542. Epub 2012 Feb 11.
10
Extra-corporeal membrane oxygenation in paediatric acute respiratory distress syndrome: overrated or underutilized?小儿急性呼吸窘迫综合征中的体外膜肺氧合：是被高估还是未得到充分利用？
Ann Transl Med. 2019 Oct;7(19):512. doi: 10.21037/atm.2019.09.27.
引用本文的文献
1
The use of extracorporeal membrane oxygenation in COVID-19: a systematic review.体外膜肺氧合在新型冠状病毒肺炎中的应用：一项系统综述
Arch Med Sci. 2023 Jan 20;21(3):897-918. doi: 10.5114/aoms/152022. eCollection 2025.
2
Measuring and visualizing scattered x-rays using red-green-blue (RGB) heat maps during extracorporeal membrane oxygenation in the intensive care unit.在重症监护病房进行体外膜肺氧合期间，使用红-绿-蓝（RGB）热图测量和可视化散射X射线。
BMC Res Notes. 2025 May 16;18(1):220. doi: 10.1186/s13104-025-07286-0.
3
In COVID-19 Patients Supported with Extracorporeal Membrane Oxygenation, Intensive Care Unit Mortality Is Associated with the Blood Transfusion Rate.在接受体外膜肺氧合支持的新冠肺炎患者中，重症监护病房死亡率与输血率相关。
J Clin Med. 2024 Dec 4;13(23):7381. doi: 10.3390/jcm13237381.
4
Extracorporeal membrane oxygenation: unmet needs and perspectives.体外膜肺氧合：未满足的需求与展望
Rheumatol Int. 2024 Dec;44(12):2745-2756. doi: 10.1007/s00296-024-05732-z. Epub 2024 Oct 16.
5
Utilisation and outcomes of a mobile (ambulance and air transport) venovenous extracorporeal membrane oxygenation (VV-ECMO) program in Poland during the COVID-19 pandemic - a retrospective, two-centres, case-series study.在 COVID-19 大流行期间，波兰移动（救护车和空中运输）静脉-静脉体外膜肺氧合（VV-ECMO）项目的使用情况和结果 - 一项回顾性、双中心、病例系列研究。
Anaesthesiol Intensive Ther. 2024;56(2):141-145. doi: 10.5114/ait.2024.139526.
6
ECMO is associated with decreased hospital mortality in COVID-19 ARDS.ECMO 与 COVID-19 所致 ARDS 患者的住院死亡率降低相关。
Sci Rep. 2024 Jun 27;14(1):14835. doi: 10.1038/s41598-024-64949-x.
7
Nitric oxide and viral infection: Recent developments in antiviral therapies and platforms.一氧化氮与病毒感染：抗病毒疗法及平台的最新进展
Appl Mater Today. 2021 Mar;22:100887. doi: 10.1016/j.apmt.2020.100887. Epub 2020 Dec 5.
8
Outcomes of Severe ARDS COVID-19 Patients Denied for Venovenous ECMO Support: A Prospective Observational Comparative Study.被拒绝接受静脉-静脉体外膜肺氧合支持的重症新型冠状病毒肺炎急性呼吸窘迫综合征患者的结局：一项前瞻性观察性比较研究
J Clin Med. 2024 Mar 5;13(5):1493. doi: 10.3390/jcm13051493.
9
Extracorporeal membrane oxygenation for COVID-19-associated severe acute respiratory distress syndrome in Canada: Analysis of data from the Canadian Nosocomial Infection Surveillance Program.加拿大体外膜肺氧合治疗新型冠状病毒肺炎相关重症急性呼吸窘迫综合征：来自加拿大医院感染监测项目的数据分析
J Assoc Med Microbiol Infect Dis Can. 2024 Jan 16;8(4):272-282. doi: 10.3138/jammi-2023-0015. eCollection 2024 Jan.
10
Extracorporeal Life Support Organization Registry International Report 2022: 100,000 Survivors.体外生命支持组织注册国际报告 2022：10 万名幸存者。
ASAIO J. 2024 Feb 1;70(2):131-143. doi: 10.1097/MAT.0000000000002128. Epub 2024 Jan 5.
Zotero 插件